Streamline Health Solutions (STRM) Financials
$5.33
As on 12-Aug-2025 09:30EDT
Market cap
$23 Mln
Revenue (TTM)
$18 Mln
P/E Ratio
--
P/B Ratio
2.1
Div. Yield
0 %
Income Statement ($ Mln) |
TTM | Jan-25 | Jan-24 | Jan-23 | Jan-22 | Jan-21 | Jan-20 | Jan-19 | Jan-18 | Jan-17 | Jan-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
18.38
|
17.90
|
22.60
|
24.89
|
17.38
|
11.35
|
|||||
|
Cost of Revenue
|
9.50
|
9.56
|
11.05
|
13.40
|
8.58
|
5.69
|
|||||
|
Gross Profit
|
8.88
|
8.34
|
11.54
|
11.49
|
8.80
|
5.66
|
|||||
|
Operating Expenses
|
18.28
|
16.37
|
31.19
|
22.33
|
19.57
|
11.50
|
|||||
|
Operating Profit (EBIT)
|
-6.88
|
-8.03
|
-19.65
|
-10.83
|
-10.77
|
-5.84
|
|||||
|
Other Income
|
--
|
--
|
--
|
0.20
|
--
|
-0.06
|
|||||
|
Profit before Tax
|
-9.07
|
-10.16
|
-18.74
|
-11.31
|
-6.81
|
-6.06
|
|||||
|
Provision for Tax
|
0.50
|
--
|
-0.05
|
0.07
|
0.11
|
-1.26
|
|||||
|
Profit after Tax (Net Income)
|
-9.07
|
-10.16
|
-18.70
|
-11.38
|
-6.92
|
-4.80
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Consolidated Profit
|
--
|
--
|
--
|
-11.38
|
-6.54
|
0.30
|
Liabilities ($ Mln) |
TTM | Jan-25 | Jan-24 | Jan-23 | Jan-22 | Jan-21 | Jan-20 | Jan-19 | Jan-18 | Jan-17 | Jan-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
11.06
|
12.28
|
18.81
|
35.51
|
34.04
|
17.49
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Non-Current Liabilities
|
0.12
|
0.24
|
9.24
|
9.24
|
14.27
|
1.12
|
|||||
|
Current Liabilities
|
24.66
|
23.06
|
13.68
|
16.78
|
13.50
|
7.37
|
|||||
|
Total Liabilities
|
60.48
|
35.58
|
41.74
|
61.52
|
61.82
|
25.98
|
Assets ($ Mln) |
TTM | Jan-25 | Jan-24 | Jan-23 | Jan-22 | Jan-21 | Jan-20 | Jan-19 | Jan-18 | Jan-17 | Jan-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
29.25
|
29.80
|
32.90
|
45.53
|
46.70
|
18.66
|
|||||
|
Current Assets
|
6.58
|
5.78
|
8.84
|
15.99
|
15.12
|
7.32
|
|||||
|
Total Assets
|
60.48
|
35.58
|
41.74
|
61.52
|
61.82
|
25.98
|
|||||
|
Total Debt*
|
13.98
|
13.12
|
10.57
|
9.75
|
10.14
|
2.72
|
|||||
|
Net Current Assets
|
-18.08
|
-17.29
|
-4.85
|
-0.79
|
1.62
|
-0.05
|
Cashflow ($ Mln) |
TTM | Jan-25 | Jan-24 | Jan-23 | Jan-22 | Jan-21 | Jan-20 | Jan-19 | Jan-18 | Jan-17 | Jan-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
-1.51
|
-2.22
|
-7.14
|
-3.50
|
-5.76
|
|||||
|
Cash Flow from Investing Activities
|
--
|
-0.86
|
-1.62
|
-1.94
|
-13.17
|
9.46
|
|||||
|
Cash from Financing Activities
|
--
|
1.37
|
0.43
|
5.79
|
24.15
|
-2.94
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
--
|
--
|
-3.29
|
--
|
3.02
|
Financials Ratios |
TTM | Jan-25 | Jan-24 | Jan-23 | Jan-22 | Jan-21 | Jan-20 | Jan-19 | Jan-18 | Jan-17 | Jan-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash EPS ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Adjusted Book Value ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Dividend per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Free Cash Flow per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
Profitability Ratios |
TTM | Jan-25 | Jan-24 | Jan-23 | Jan-22 | Jan-21 | Jan-20 | Jan-19 | Jan-18 | Jan-17 | Jan-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
-37.09
|
-50.10
|
-25.44
|
-21.48
|
-23.97
|
|||||
|
ROE (%)
|
-72.61
|
-65.35
|
-68.83
|
-32.72
|
-26.84
|
-28.66
|
|||||
|
ROA (%)
|
-15.76
|
-26.28
|
-36.21
|
-18.45
|
-15.76
|
-16.66
|
|||||
|
EBIT Margin (%)
|
-29.32
|
-45.51
|
-78.21
|
-44.62
|
-37.82
|
-65.00
|
|||||
|
Net Margin (%)
|
-49.32
|
-56.75
|
-82.74
|
-45.35
|
-39.80
|
-42.53
|
|||||
|
Cash Profit Margin (%)
|
0.00
|
--
|
--
|
--
|
--
|
--
|
Growth Ratios |
TTM | Jan-25 | Jan-24 | Jan-23 | Jan-22 | Jan-21 | Jan-20 | Jan-19 | Jan-18 | Jan-17 | Jan-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-14.88
|
-0.21
|
-0.09
|
0.43
|
0.53
|
-0.45
|
|||||
|
EBIT Growth (%)
|
68.93
|
53.90
|
-59.14
|
-68.97
|
10.89
|
2.54
|
|||||
|
Net Profit Growth (%)
|
51.09
|
45.67
|
-64.31
|
-64.51
|
-44.13
|
-67.62
|
|||||
|
EPS Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Book Value Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
Valuation Ratios |
TTM | Jan-25 | Jan-24 | Jan-23 | Jan-22 | Jan-21 | Jan-20 | Jan-19 | Jan-18 | Jan-17 | Jan-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Price / Book Value
|
2.10
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
-24.03
|
-3.32
|
-0.58
|
-0.50
|
-0.09
|
0.10
|
|||||
|
Close Price ($)
|
2.96
|
4.60
|
5.85
|
32.40
|
20.55
|
27.75
|
|||||
|
High Price ($)
|
9.75
|
9.75
|
35.25
|
32.85
|
57.90
|
28.80
|
|||||
|
Low Price ($)
|
1.82
|
1.85
|
3.15
|
15.60
|
18.30
|
7.94
|
|||||
|
Market Cap ($ Cr)
|
23.23
|
--
|
--
|
--
|
--
|
--
|
Solvency Ratios |
TTM | Jan-25 | Jan-24 | Jan-23 | Jan-22 | Jan-21 | Jan-20 | Jan-19 | Jan-18 | Jan-17 | Jan-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
1.07
|
0.56
|
0.27
|
0.30
|
0.16
|
|||||
|
Short term debt to equity ratio
|
1.26
|
1.07
|
0.08
|
0.02
|
0.01
|
0.10
|
|||||
|
Current Ratio
|
0.27
|
0.25
|
0.65
|
0.95
|
1.12
|
0.99
|
|||||
|
Quick Ratio
|
0.27
|
--
|
--
|
0.95
|
1.12
|
0.80
|
|||||
|
Interest Coverage
|
-3.34
|
-4.05
|
-16.50
|
-14.83
|
-27.85
|
-144.61
|
Operating Efficiency Ratios |
TTM | Jan-25 | Jan-24 | Jan-23 | Jan-22 | Jan-21 | Jan-20 | Jan-19 | Jan-18 | Jan-17 | Jan-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
26.23
|
17.63
|
22.20
|
34.87
|
26.85
|
27.35
|
|||||
|
Asset Turnover
|
0.32
|
0.46
|
0.44
|
0.40
|
0.40
|
0.39
|
|||||
|
Receivable days
|
--
|
83.38
|
110.69
|
97.92
|
81.64
|
95.32
|
|||||
|
Inventory Days
|
--
|
--
|
0.00
|
0.00
|
29.53
|
89.05
|
|||||
|
Payable days
|
--
|
53.36
|
31.05
|
19.14
|
22.36
|
33.00
|
|||||
|
Cash Conversion Cycle
|
--
|
--
|
79.65
|
78.78
|
88.82
|
151.37
|